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There is ongoing controversy regarding the association between vesicoureteric reﬂux (VUR), recurrent urinary tract infections
(UTI), and renal damage. Despite this, routine work up for VUR is still recommended after febrile UTI in most children. The
present article reviews the indications and imaging modalities available for VUR diagnosis. Alternative newer techniques like MR
cystography and voiding urosonography are discussed. The increasing evidence of the role of DMSA scans in managing children
with VUR is highlighted.
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1. INTRODUCTION
The goals of an imaging procedure in general are to conﬁrm
the diagnosis suspected with a high degree of sensitivity and
speciﬁcity, to aid treatment and allow prognostication. On
the other hand, it is obligatory for the treating physician to
analyze the risks and beneﬁts of the diagnostic procedure
and understand the natural history of the disease in question
to establish whether or not the diagnosis and treatment
of a condition would alter long term outcome or impact
management decisions.
The diagnosis of vesicoureteric reﬂux (VUR) is a rela-
tively straightforward and well-established procedure. How-
ever, the underlying rationale for identifying VUR to prevent
recurrent pyelonephritis (PN) and long-term renal damage
has been vigorously questioned in the recent literature [1–4].
Coupled with this, there has been the increasing awareness
of the risks of radiation exposure and the realization that
VUR investigation is an invasive procedure and deﬁnitely
an unpleasant experience. Therefore, it is imperative for
the pediatric urologist and nephrologist to reevaluate the
indications and goals for imaging for VUR, redeﬁne the
modalities used, and establish guidelines for followup.
The current article reviews the available modalities for
evaluatingVUR,suggestsprotocolsforinvestigating children
with suspected VUR, and presents the recent evidence
justifying these recommendations.
2. IMAGING MODALITIES FOR DIAGNOSIS OF VUR
2.1. Voidingcystourethrogram(VCUG)or
radionuclidecystogram(RNC)
An ideal test for VUR detection would be one involving
no radiation, no bladder catheterization, no sedation, low
cost, high sensitivity, and one which provides complete
anatomical details. The traditional method for diagnosing
VUR is the ﬂuoroscopic voiding cystourethrogram (VCUG).
Currently, radionuclide cystography (RNC) remains the
primary alternative to a VCUG in evaluating VUR. The
objection to performing a VCUG is related to the high
radiation exposure of a traditional VCUG which is believed
to be about 100 times that of a RNC. However, with
the judicious use of digital and pulsed ﬂuoroscopy with
meticulous image coning, the radiation exposure from a
VCUG has been signiﬁcantly reduced [5]. Despite these
measures, the average ovarian radiation dose was shown to
beabout10timesgreaterinaVCUGwhencomparedwithan
RNC [6]. The proponents of RNC argue that this eﬀectively
reduces the sensitivity of the VCUG in identifying VUR as
snapshots of the bladder ﬁlling and voiding are taken rather
than continuous imaging. In an editorial comment, Benson
stated that “the radiation dose given during 3 minutes of
ﬂuoroscopy time approximates that of two pelvic spiral
CT scans with contrast, 1.5 conventional abdominal CT2 Advances in Urology
scans without contrast, 3 DMSA scans, 60 abdominal plain
ﬁlms, 600 radionuclide VCUG’s, or 10 years of background
radiation” [7].
Several studies have compared the sensitivity of VCUG
and RNC and concluded that RNC is at least as sensitive as
or more than a VCUG for detecting VUR [8–10]. S¨ ukan et al.
observed no signiﬁcant diﬀerence between the 2 modalities
b u tn o t e dt h a tR N Co ﬀered a higher sensitivity in the
younger age group [8]. Moreover, despite not reaching sta-
tistical signiﬁcance, in children with a positive dimercapto-
succinic acid (DMSA) scan, RNC identiﬁed VUR in a higher
percentage of children as opposed to the VCUG. This is a
relevant ﬁnding in the current era where a positive DMSA
scan is believed to be an important ﬁnding in children
presenting with PN (as discussed later). An insigniﬁcant
grade 1 VUR may be missed on an RNC but the continuous
imagingduringﬁllingandvoidingallowsgreaterdetectionof
VUR, which is an intermittent phenomenon. For both tests,
it is well established that a cyclic study should be performed
toincreasethedetectionofVUR[11].Thedeﬁniteadvantage
a VCUG has over an RNC lies in the anatomical information
obtained by the former especially in evaluating the urethra
in males. Moreover, the International Reﬂux grading system
is based on the VCUG and since most studies on VUR
have used this grading system, treating physicians feel more
comfortable in knowing this information. However, again as
a result of change in treatment philosophy, it can be argued
that a broader classiﬁcation of VUR into dilating (≥Grade
3) and nondilating varieties is possible on an RNC, making
this an insigniﬁcant issue when deciding on the study to
obtain. Therefore, currently VCUG remains the standard
when initially evaluating a child with suspected VUR. For
all subsequent studies, the RNC is the preferred modality.
Medina et al. performed a cost analysis of VUR imaging
usingVCUGandRNC,highlightinganotherpotentialreason
for preferring the RNC for followup imaging [12]. The study
showed that the direct costs of performing a VCUG was 1.74
times higher than an RNC (P<. 001).
2.2. IndirectRNC
The indirect RNC oﬀers the possibility of detecting VUR
without bladder catheterization and presumably in a more
physiological setting with natural bladder ﬁlling. The addi-
tional advantage is the ability to assess upper tract diﬀer-
ential function and drainage with the injected radioisotope.
Although a few reports have shown a comparable degree
of sensitivity between the direct and indirect RNC, the
consensus is that due to an inability to study the ﬁlling phase
with an indirect RNC there is a considerable false negative
rate with indirect RNC [13–15] .T h e r em a yb ear o l eo ft h e
indirect RNC as a followup study in children who are toilet
trained [14].
2.3. Voidingurosonography(VUS)
The sonographic evaluation of VUR following intravesical
instillation of US contrast agent has gradually popularized
VUS over the last decade. In a comprehensive review of VUS
when compared with VCUG, Darge showed that in 1338
patients with 2893 reﬂuxing units, VUS showed a diagnostic
accuracy of 78%–96% [16]. The overall agreement between
the 2 studies was 91% and in 9% of renal units VUR was
detected only on VUS making it the more sensitive study.
AnotherpotentialadvantageoftheVUSascomparedtoRNC
istheabilitytogradeVURsimilartotheInternationalReﬂux
grading system with a 75% concordance shown between
the VUS and VCUG grading. The discordant ﬁndings
are primarily because of a signiﬁcant number of grade-
1 VUR on VCUG being grade 2 or higher on VUS. The
absence of radiation, the ability to evaluate the upper tracts
simultaneouslyanditshighersensitivitymakeitanattractive
tool for evaluating VUR. The potential drawbacks include
inadequate evaluation of bladder and urethral morphology,
higher costs of contrast agent, longer exam time, and its
operatordependence.TransperinealUSoftheurethraaspart
of the VUS has been used reliably in a few studies to date
but further evaluation of this technique is necessary before
VUS can replace the VCUG as the ﬁrst examination for VUR
especiallyinboys[17].Atpresent,VUShasaroleinfollowup
examinations for VUR, for screening siblings and possibly as
the ﬁrst examination for VUR in girls.
2.4. MRvoidingcystography(MRVCUG)
MR cystography involves intravesical administration of
gadolinium with imaging using MR during ﬁlling and
voiding. The relative beneﬁts of the procedure are that it can
evaluate VUR without ionizing radiation and additionally
give important information about renal-acquired cortical
defects and diﬀerentiate acquired cortical defects from con-
genitaldysplasia.Itmustbeborneinmindthatdysplasiaand
scarring are diﬀerent entities diagnosed on histopathological
examination.Inthispaperwerefertothemascongenitaland
acquired cortical defects. The potential drawbacks include
a lower sensitivity as compared to VCUG, higher costs,
and the need for sedation or anesthesia to perform the
study. Takazakura et al. showed 90% sensitivity and a 96%
speciﬁcity of MRVCUG and all children with grade 3 or
more VUR were identiﬁed using this modality [18]. Lee et
al. further correlated the MRVCUG ﬁndings with a DMSA
SPECT scan to demonstrate the advantage of getting this
additional information with a single test [19].
2.5. PICcystogram
Rubensteinetal.in2003introducedanovelbutcontroversial
techniquetoidentifyVURinchildrenpresentingwithfebrile
UTIs and negative VCUG [20]. The authors performed the
PIC (Positioning the Instillation of Contrast at the ureteral
oriﬁce) cystogram by positioning the cystoscope close to
the ureteric oriﬁce with the bladder empty and instilling
contrast in gravity-aided manner from a height of 1m using
the irrigation port of the scope. The argument that this
technique could induce VUR was countered by using a
control group of children without UTI and VUR where the
PIC cystogram also did not demonstrate reﬂux. In contrast,
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VUR on the PIC cystogram. A multi-institutional study
conﬁrmed that PIC VUR could be demonstrated in 82% of
children who present with febrile UTI and normal VCUG
[21]. The inherent problem with both these studies has been
the lack of standardization of the VCUG technique used,
absence of upper tract imaging ﬁndings, and strict deﬁnition
of UTI. This latter objection has been addressed in a more
recent study by Tareen et al. who evaluated 5 children with
recurrent febrile UTI and upper tract changes on DMSA/CT
scan [7]. All 5 patients showed VUR on PIC cystography
and went on to endoscopic or open VUR correction. The
results of these studies indicate that the majority of children
with febrile UTI and no VUR on a VCUG would have
VUR on a PIC cystogram. Before adding this investigation
as a routine modality for children with febrile UTI and
negative VCUGs, further prospective randomized studies are
indicated to deﬁne the population who would beneﬁt from
this intervention.
3. INDICATIONS FOR IMAGING FOR SUSPECTED VUR
The primary indications for evaluating children for VUR
are discussed in this section. There has been considerable
evolution of our knowledge about VUR management over
the last several years. The role of antibiotic prophylaxis
in preventing recurrent infections has been challenged
along with an increasing awareness of the development of
antibiotic resistance [1–3]. This coupled with identiﬁcation
of other stronger predicting factors for recurrent infection
likelowerurinarytractdysfunction(LUTS)hasledtoamore
conservative approach in identifying and treating VUR [22].
This section suggests recommendations for the evaluation of
children with suspected VUR.
3.1. Childrenwithurinarytractinfection
The American Academy of Pediatrics: Committee on Quality
Improvement recommends a VCUG for all children aged
between 2 months to 2 years old following the ﬁrst febrile
UTI [23]. The rationale for this practice is based on the
traditional view that there is always uncertainty about
whether previous infections were missed, high recurrence
rates of UTI, high percentage of children with UTI having
VUR and that the risk of renal-acquired cortical defects
is highest in younger children. In practice, however, this
recommendation is often not followed rigidly primarily
because of poor documentation of signiﬁcant bacteriuria
and pyuria which puts in doubt the diagnosis of a UTI. For
older children, age at presentation, gender, race, type (febrile
or non febrile), frequency of UTI, and social factors must
be considered before proceeding to a VCUG. Toilet-trained
female children with cystitis are primarily evaluated by a full
voiding diary and the dysfunctional voiding symptom score
(DVSS) rather than a VCUG [24]. In children with recurrent
cystitis a uroﬂowmetry and US are added. However, in the
presence of a well-documented episode of PN or recurrent
febrileUTI,aVCUGorRNCiswarrantedalongwithaUSor
DMSA scan to assess the upper tracts. All males with a well-
documented febrile UTI should undergo a VCUG. Because
of the well-documented low incidence of VUR in black
children, a VCUG is not indicated for older black children
presenting with UTI. The initial VCUG can be performed
after the child is afebrile, clinically stable and the urine is
sterile [25]. The dose of antibiotic prophylaxis is doubled a
day before the test and continued at therapeutic levels for
another day following the test.
3.2. SiblingVUR
Primary VUR is the commonest heritable disorder of the
genitourinarytractandisinheritedasaMendeliandominant
with partial expression [26]. Several studies on sibling VUR
have identiﬁed factors, which can help predict the risk of
siblingVUR.Hollowellinananalysisof1768siblingsshowed
a mean VUR incidence of 32%, which was 44% in siblings
less than 2 years of age as compared to 9% of siblings greater
than 6 years [27]. If the sex of the sibling or proband is
considered separately there is no statistical association. On
the other hand, female siblings of the female index patient
haveahigherlikelihoodofVURthantheirmalecounterparts
[28]. Monozygotic twins have an obviously higher risk than
dizygotic twins. Hollowell showed that approximately two-
thirds of siblings have low grade (I, II) VUR and the
spontaneous resolution rate is higher when compared to
children diagnosed with VUR after a UTI [27]. Giel et al.
presented the long-term outcome of asymptomatic siblings
screened for VUR with an initial US [29]. Of the 117 siblings
inthisstudy,11(9.4%)hadabnormalUSﬁndings,5ofwhich
showed VUR on a VCUG. In 85 siblings with an average
followup of more than 8 years, none had complications
of VUR. Other authors have argued for a more proactive
approach in diagnosing VUR in siblings [30, 31]. Houle et al.
demonstrated a 26% incidence of cortical defects in siblings
and indicated that siblings screened after 2 years of age had a
higher risk of renal damage [30]. The alternative argument
here is that perhaps these ﬁndings represent congenital
defects rather than acquired preventable defects.
A tailored approach for siblings therefore could be an
RNC or a VUS in siblings younger than the toilet-trained
age and US as the initial screening modality for all older
siblings. In the presence of any US evidence of cortical
damage a VCUG is recommended in children under 5 years
of age as they form the subset most at risk of renal damage.
Symptomatic siblings at any age are evaluated with a VCUG.
3.3. PrenatalhydronephrosisandVUR
VUR is suspected antenatally in the presence of ureteric
dilatation and/or hydronephrosis (HN) or following the
diagnosis of ectopic kidneys, multicystic dysplastic kidney,
and unilateral renal agenesis wherein there is an increased
incidence of contra lateral VUR. Van Eerde et al. performed
a meta-analysis to review the value of antenatal HN in
predicting postnatal VUR [32]. HN was deﬁned as renal
pelvic diameter more than 4mm with or without caliectasis.
Among the 1178 cases, the mean prevalence of primary VUR
was 14.9%. When stratiﬁed by anteroposterior renal pelvic
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APD ≤ 10mm and in 12% of infants with APD ≥ 10mm.
It is known that a negative prenatal screening or a normal
postnatal US in infants with antenatal HN does not rule
out VUR. In a meta-analysis reported by Lee et al., the
prevalence of VUR ranged between 4.4% and 14% [33].
There was no correlation between the degree of prenatal
HN and the presence or grade of VUR. Similarly, in another
study conducted on 108 children with antenatal HN, VUR
was detected in 15% and there was no correlation between
the degree of pelviectasis on postnatal US and the presence
or severity of VUR [34]. Children with antenatal HN and
VURhaveamorebenigncoursewithahigherresolutionrate
when compared to children diagnosed with VUR following
aU T I[ 35, 36]. Upadhyay et al. followed 25 children with
antenatally detected HN and VUR [36]. Reﬂux was greater
than or equal to grade III in 70% of children. VUR resolved
in 52% and was downgraded in 24%. Breakthrough urinary
tract infection occurred in 4 patients with grades IV and V
reﬂux, and dysfunctional voiding developed in 5. Followup
renal scans showed decreased diﬀerential function (mean
18%) in 2 units without new scars. A selective approach
is advisable for investigating neonates with antenatal HN.
If the renal size and parenchyma is unremarkable, it may
be reasonable to reserve the VCUG for children with SFU
grade 3-4 HN or bilateral HN and in the presence of ureteric
dilatation.
3.4. Othersituations
A routine VCUG is recommended in the work up of children
with multicystic dysplastic kidneys (MCDK) based on the
reported 15%–25% prevalence of VUR in children with
MCDK [37–40]. Miller et al. found a 25% VUR rate in the
contralateral kidney in 75 patients with MCDK [37]. In this
series, about 50% of children with VUR had grades ≥3, 50%
resolved spontaneously by 5 years of age and only 1 of the
75 children required surgical intervention for VUR. Guarino
et al. documented that 16% of children with MCDK had
VUR and the VUR grade was signiﬁcantly higher in boys as
compared to girls [39]. This ﬁnding was also noted in the
studybySelzmanandElder,wherein15%ofchildrenshowed
contralateral VUR, with the prevalence being higher in boys
and the white population [40]. Ismaili et al. recommended
that 2 successive normal US studies in the neonatal period
identiﬁe most signiﬁcant contralateral anomalies avoiding
the use of a routine VCUG [38]. In their study, 61 of
the 76 newborns with MCDK had 2 normal neonatal US.
Among them, 4 (7%) had low grade VUR which resolved
spontaneously in all before 2 years of age. Further studies
are needed to validate this ﬁnding before stopping routine
VCUGs in children with MCDK.
The incidence of VUR in children with unilateral renal
agenesis (URA) is slightly higher than MCDK and varies
between 24%–28% [39, 41–43]. The VUR can be high grade
and shows a lower spontaneous resolution rate as compared
to MCDK [41]. Arena et al. evaluated 60 children with
renal ectopia (crossed 24, simple 36) [44]. The authors
recommended complete urological evaluation of children
presenting with renal ectopia. The incidence of associated
VUR was 37% with crossed ectopia and 17% with simple
ectopia. Unlike MCDK, Guarino et al. noted that girls had
a higher grade of VUR and lower resolution rates [39]. In
viewofthehighincidenceofneurogenicbladderdysfunction
and VUR (20%–47%) children with anorectal malformation
should also undergo a VCUG [45].
4. WHAT SHOULD THE FIRST INVESTIGATION
FOLLOWING PYELONEPHRITIS BE:
DMSA OR VCUG?
Primary VUR occurs in less than 1% of the general
population but up to 50% of children who present with a
U T Iw i l lh a v eV U R[ 46]. Therefore, the detection of VUR
is an abnormal ﬁnding. The primary reason for identifying
VUR as a disease entity has been its association with
pyelonephritis(PN),which,ifrecurrent,canleadtoacquired
cortical defects and subsequent hypertension and/or end
stage renal failure. This perception that the triad of UTI-
VUR-nephropathy is an intimate link has driven physicians
to actively diagnose and treat VUR over the last 3 decades.
There is a considerable debate regarding the initial
investigation following a febrile UTI with several studies
highlighting the emerging role of DMSA scan vis a vis the
VCUG. The rationale for this argument stems from the
recent evidence which has downgraded the importance of
VUR as a sole factor in causing long-term renal damage. In
fact, our aggressive management of VUR over the last several
decades has not impacted long-term renal outcome. Craig
et al. reviewed the Australia and New Zealand Dialysis and
Transplant Registry between 1971 and 1998 and noted that
overthedecades,despiteamoreaggressiveidentiﬁcationand
treatmentofVUR,reﬂuxnephropathycontinuedtoremaina
cause of ESRD in about 14% of children registered [47]. This
section discusses this current thought process and refocuses
our attention to our primary goal which is the identiﬁcation
of risk factors which lead to progressive renal damage.
4.1. Pyelonephritisandacquiredcortical
defectscanoccurwithoutVUR
Recent studies have demonstrated that acquired renal scar-
ring correlates best with recurrent UTI and not with VUR
a n dp r i m a r yV U Ri sn e i t h e rs u ﬃcient nor essential for
r e n a ld a m a g e .T h ee x c e p t i o nt ot h i sr u l ei ss e c o n d a r y
reﬂux associated with bladder outlet obstruction or high-
pressure neurogenic bladders. Gordon et al. performed a
meta-analysis to determine the value of VUR diagnosis to
predict renal damage in children hospitalized with UTI [4].
The analysis evaluated 12 studies comprising 537 children
with 1032 kidneys and showed that primary VUR was
a poor predictor of renal damage on a DMSA scan in
children hospitalized with UTI. A positive VCUG increased
the chance of a positive DMSA scan by only about 20%
whereas a negative VCUG increased the chance of nega-
tive DMSA scan by 8%. The authors concluded that the
VCUG could not be used as a primary screening test to
detect renal parenchymal damage in children with UTI.
Taskinen and R¨ onnholm noted that fever more than 39
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Table 1: Results of studies analyzing concordance between DMSA and VCUG ﬁndings.
Study (N) POS DMSA POS VCUG POS DMSA NEG VCUG NEG DMSA POS VCUG NEG DMSA NEG VCUG
Hansson et al. (303) 53 (17%) 103 (34%) 27(9%);≥ III VUR in 7 120 (39%)
Tseng et al. (142) 37 (26%) 64 (45%) 5(3.5%);≥ III VUR in 0 36 (25%)
Preda et al. (290) 44 (15%) 105 (36%) 8(2.7%);≥ III VUR in 1 133 (46%)
CRP > 100mg/mL, and proteinuria during UTI were
predictors of renal damage [48]. The presence of VUR did
not increase the risk of renal defects on DMSA scanning.
On followup, DMSA scans 2 years following UTI, 9 of the
12 patients who showed evidence of cortical defects did not
have associated VUR.
4.2. CorticaldefectsinchildrenwithVUR
predictsrecurrentinfection
Mingin et al. retrospectively reviewed records of children
who underwent DMSA scans following a febrile UTI or
antenatal HN [49]. 88% of the children with an abnormal
DMSA scan had grade 3–5 VUR. Of the 51 children with an
abnormal DMSA and grade 3–5 VUR 60% had a subsequent
breakthrough UTI. In comparison, only 6% of children with
similar VUR grade and a normal DMSA scan developed
breakthrough infection. Furthermore, only 5% of children
with an abnormal DMSA scan showed improvement in VUR
grade on followup as compared to a 46% resolution rate
in those without DMSA abnormality, a fact only partly
attributable to the lower initial grade of VUR in this subset.
4.3. ApositiveDMSAscanidentiﬁessigniﬁcant
VURinmostinstances
In 303 children less than 2 years of age evaluated with VCUG
and DMSA scans after an episode of UTI, Hansson et al.
found that 51% had an abnormal DMSA scan and 46% with
a positive DMSA scan had no evidence of VUR on VCUG
[50]. There was a signiﬁcant association between ≥grade III
VUR and DMSA positive renal lesions. A normal DMSA
scan and dilating VUR were found in only 7 children in
this study, of which only 1 showed a scarred kidney on
followup. None of the 7 children had recurrent UTI on
followup. The authors suggested that DMSA could replace
VCUG as the primary evaluation for children following a
UTI. VCUGs could be selectively performed in children with
abnormalities on DMSA scans and this would reduce the
number of VCUGs by about half based on the results of
this study. The same group conducted a further prospective
studytotestthishypothesis[51].In290childrenwithUTIin
infancy, 52 had VUR which was dilating in 27. An abnormal
DMSA scan was documented in 26 of the 27 children with
dilating VUR. Tseng et al. also attempted to answer this
question whether a normal DMSA can obviate the need for
a VCUG following the ﬁrst UTI [52]. In 142 children, only 5
children with a normal DMSA scan had VUR (all less than
or equal to grade 2) and no child with dilating reﬂux had a
normal DMSA scan. Table 1 summarizes these results.
4.4. Antibioticprophylaxisdoesnotpreventrecurrent
UTIinchildrenwithlow-gradeVUR
The role of VUR, especially lower grades, as a predisposing
factor for recurrent UTI is also controversial. Nuutinen and
Uhari noted a higher rate of recurrent UTIs in children with
grade III–V VUR in comparison with children with grade
I-II VUR [53]. It is now believed that the susceptibility for
recurrentUTIismorerelatedtoadefectiveurothelialdefense
mechanism and bladder dysfunction rather than associated
VUR. Roussey-Kessler et al. conducted a prospective study
on children with grade 1–3 VUR randomized to receive
cotrimoxazole or no treatment with UTI on followup as an
end point [3]. There was no signiﬁcant diﬀerence in the
o c c u r r e n c eo fU T Ii nb o t hg r o u p se x c e p ti nb o y sw i t hg r a d e
3 VUR (P = .04). Garin et al. performed a randomized
prospective trial in 218 children with or without VUR
who presented with PN, comparing prophylaxis with no
prophylaxis [2]. The study only included patients with grade
I–III VUR. No statistically signiﬁcant diﬀerences were found
among the groups with respect to the rate of recurrent UTI,
type of recurrence, rate of subsequent pyelonephritis, and
development of renal parenchymal scars. The overall rate
of recurrent PN in this study was 5.5% and VUR did not
increase the likelihood of PN. The authors concluded that
at 1-year followup, grade I–III VUR did not increase the
incidence of UTI, PN, or cortical defects. Conway et al.
performed a time-to-event analysis on 611 children who are
presented with the ﬁrst UTI to determine the association
between antibiotic prophylaxis and recurrent UTI and to
identifyriskfactorsforresistance[54].Thefactorsassociated
with an increased risk of recurrent UTI in this study were
white race, age between 3–5 years, and grade IV-V VUR.
Sex and grade I–III VUR were not associated with the
risk of recurrence. Moreover, antibiotic prophylaxis was
not associated with a decreased risk of recurrent UTI in a
multivariable analysis but was a risk factor for antibiotic
resistance among children with recurrent UTI.
The problem in interpreting studies attempting to clarify
this aspect is the lack of a standardized deﬁnition of a febrile
UTI and the variability in the methodology of obtaining
urine samples. The ongoing randomized intervention for
children with vesicoureteric reﬂux (RIVUR) study is a
multicenter,doubleblinded,randomized,placebocontrolled
trialwhichaimstoanswertheongoingcontroversyregarding
the role of antibiotic prophylaxis in preventing recurrent6 Advances in Urology
febrile/symptomatic UTI in children with VUR diagnosed
after a UTI.
In summary:
(1) in children presented with a UTI, up to 50% of
children may have evidence of upper tract damage
without evidence of VUR on a VCUG;
(2) the rate of spontaneous resolution of VUR is higher
inchildrenwithlow-gradeVURandanormalDMSA
scan;
(3) a positive DMSA scan at diagnosis predicts a higher
rate of recurrent UTI or breakthrough infections in
children with VUR;
(4) VUR identiﬁcation has not altered the ESRD rate
related to reﬂux nephropathy.
Theideabehindthesestudiesistoencourageamoreselective
approach in investigating children who present with a ﬁrst
UTI, contrary to the AAP practice guidelines. A DMSA
would be the initial investigation and all children with an
abnormal DMSA will then proceed to a VCUG. This would
identify the majority of children with dilating/signiﬁcant
VUR who would then beneﬁt from antibiotic prophylaxis,
thus reducing both the number of VCUGs and number
of children on antibiotic prophylaxis. Such a selective
approach is justiﬁable with one objection being that boys
with a potential posterior urethral valve presented outside
the neonatal period may be missed with this approach.
However, this may be unlikely if a US study is simultaneously
performed as part of the routine work up.
4.5. MRurography(MRU)
MRU is increasingly being advocated as a single imaging
modality,whichcanbeusedtoprovideinformationobtained
on a VCUG and DMSA scan. The primary advantage of
the MRU is its ability to distinguish between renal dysplasia
(congenital cortical defects) and acquired scarring (acquired
cortical defects) [55]. In addition to morphological analysis,
MRU can provide information about renal perfusion, con-
centration, and excretion of contrast media by calculating
the renal and calyceal transit times. The Patlak diﬀerential
function and the calculated Patlak number per mL of renal
tissue is considered a surrogate for the single nephron
GFR and can therefore serve as an important tool in
prognosticating and following children with renal dysplasia.
5. FOLLOWUP IMAGING FOR VUR
The ALARA (as low as reasonably achievable) concept has
stressed the importance of minimizing radiation exposure
in children being followed conservatively after diagnosis of
VUR [5]. Thompson et al. devised a theoretical model to
study this and conducted a retrospective study in children
with primary VUR diagnosed after a UTI to evaluate
diﬀerent strategies of followup and its eﬀect on antibiotic
exposure and cost [56]. The authors recommended that
children with mild VUR undergo a VCUG every 2 years
whereas those with moderate to severe VUR should undergo
a VCUG every 3 years. In a survey of the members of the
American Association of Pediatrics published in 2001, 99%
of the respondents indicated that they would perform a
VCUG or RNC every 12–18 months in followup [57]. The
current followup protocol should aim to reduce the number
of VCUG/RNC performed while children are on antibiotic
prophylaxis basing it on the natural resolution decay curve
of VUR. It is accepted that all subsequent followup studies
following a VCUG should be an RNC.
5.1. Factorsidentiﬁedonimagingwhich
predictVURresolution
Persistence of VUR is more likely in high-grade VUR, in
children with bilateral disease (especially in Grade IV and V)
and when reﬂux is diagnosed in the older child. The value of
the VCUG and RNC in predicting VUR resolution has been
studied. It has been demonstrated that when VUR occurs at
less than 60% of expected bladder capacity and the reﬂux
volume is more than 2% of bladder capacity, the resolution
is poor [58, 59]. Knudson et al. on a multivariate analysis
stated that bladder volume on initial cystogram of greater
than 50% of predicted bladder capacity, age younger than 2
years at diagnosis, and a history of prenatal hydronephrosis
were signiﬁcant factors predicting VUR resolution within 2
years [35].
6. CONCLUSION
VUR is a heterogenous disorder, and its diagnosis and man-
agement continues to remain one of the most controversial
problems in pediatric urology. There is a realization that
rather than a disease entity, VUR is a marker of overall
urinary tract dysfunction, which may predispose to UTI.
The primary goal for the treating physician should continue
to remain preservation of renal function and preventing
the relatively small percentage of acquired renal defects
associated with VUR. There has been a paradigm shift in
the earnestness with which the diagnosis of VUR is sought
after based on an increasing body of evidence which suggests
that acquired renal defects are often not related to VUR
and that our current modalities for diagnosing VUR are
associated with unacceptable radiation exposure and bladder
catheterization. The newer modalities do hold promise but
furtherworkiswarrantedbeforetheycanreplacetheexisting
well-established techniques.
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